BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 18, 2008
View Archived Issues
Ablynx reports phase Ib results for antithrombotic nanobody ALX-0081
Read More
Milatuzumab safe in first trial in multiple myeloma
Read More
Alimera Sciences initiates pilot study to assess safety and efficacy of Iluvien
Read More
CHMP grants positive opinion for approval of Japanese Encephalitis vaccine
Read More
Potential of antileukemia combination therapy including DL-11-5908 demonstrated
Read More
Phase I and II study data for voreloxin in acute myeloid leukemia reported
Read More
FDA approves Athersys' IND to initiate phase I clinical trial of MultiStem in ischemic stroke
Read More
FDA issues complete response letter denying approval to Pain's NDA for Remoxy
Read More
FDA accepts for review Merck & Co.'s sNDA for Isentress for treatment-naive HIV-1 patients
Read More
Health Canada grants permission to EpiCept to proceed with NDS for Ceplene in AML
Read More
Companies respond to FDA panel's recommendations on LABAs in asthma
Read More
FDA accepts for review Barr's BLA for adenovirus types 4 and 7 live oral vaccines
Read More
Genta to appeal FDA negative decision on NDA for Genasense in CLL
Read More
SARcode completes phase I clinical trial of SAR-1118 for ocular inflammation
Read More
Oncolytics Biotech reports positive interim results from REO-014 phase II clinical trial of Reolysin
Read More
Phase IIa clinical trial results of LX-6171 in AAMI lead to reevaluation of future development
Read More
BioDelivery Sciences resubmits NDA for Onsolis to FDA
Read More
Health Canada approves lower dose of Bristol-Myers Squibb's Sprycel for chronic phase CML
Read More
Celsion enters exclusive Japan license agreement with Yakult Honsha for ThermoDox
Read More
Neratinib shows potent antitumor activity in advanced breast cancer phase II study
Read More
BioCancell submits IND applications for BC-819 in pancreatic and ovarian cancer
Read More
Clinical safety data supports preclinical evaluation of (+)-enantiomer of mefloquine in malaria
Read More
Recent patents report new therapeutic options for respiratory disorders
Read More
New antiinflammatory agents disclosed in recent Toyama and Galapagos patents
Read More
Novel analgesic agents imparted in recent patent literature
Read More